Figure 1.Aberrant expression of lncRNA SNHG7 and miR-122-5p existed in cervical cancer. (A and B) Relative expression of lncRNA SNHG7and miR-122-5p in cervical cancer tissues and non-tumor tissues adjacent to cervical cancer. (C and D) Relative expression of lncRNA SNHG7 and miR-122-5p in cervical cancer tissues and cisplatin-resistant cervical cancer tissues. (E) The correlation between lncRNA SNHG7 and miR-122-5p in clinical samples. (F and G) Relative expression of lncRNA SNHG7 and miR-122-5p in human cervical epithelial cell line H8 cells and human cervical cancer cell lines. (H and I) Relative expression of lncRNA SNHG7 and miR-122-5p in human cervical epithelial cell line H8 cells, human cervical cancer cell line HeLa cells and cisplatin-resistant HeLa cells. N, non-tumor tissues adjacent to cervical cancer; T, cervical cancer tissues; R, cisplatin-resistant cervical cancer tissues. CR-HeLa, cisplatin-resistant HeLa cells. **p < 0.01, ***p < 0.001.
